BioCentury
ARTICLE | Strategy

Litigation surfing on the Internet

January 3, 1995 8:00 AM UTC

Promega Corp., locked in a contract dispute with Hoffmann-La Roche, has turned to the Internet to counteract the international reach of the Swiss pharmaceutical conglomerate in their argument over the Thermus Aquaticus (Taq) DNA polymerase enzyme.

Promega (Madison, Wis.) has sued Roche, challenging the validity of the pharma company's patent for the Taq enzyme. The suit, filed in federal District Court in San Francisco, is a response to Roche's November 1992 action alleging that Promega breached its licensing agreement for the compound...